Phosphorylcholine-coated circuits improve preservation of platelet count and reduce expression of proinflammatory cytokines in CABG: A prospective randomized trial: Original articles

Journal of Cardiac Surgery

Volumn 24, Issue 4, 2009, Pages 363-368

  Schulze, Costas J ^a   Han, Lin ^b   Ghorpade, Nitin ^a   Etches, Wai S ^a   Stang, Linda ^a   Koshal, Arvind ^a   Wang, Shao Hua ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB ALPHA; INTERLEUKIN 6; PADGEM PROTEIN; PHOSPHORYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; HUMORAL IMMUNITY; MALE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

AGED; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; P-SELECTIN; PHOSPHORYLCHOLINE; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67650723349     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2009.00895.x     Document Type: Article

References (19)

1. Grover FL : The Society of Thoracic Surgeons National Database: Current status and future directions. Ann Thorac Surg 1999 68 : 367 373 discussion 374-376.
2. Kollef MH, Wragge T, Pasque C : Determinants of mortality and multiorgan dysfunction in cardiac surgery patients requiring prolonged mechanical ventilation. Chest 1995 107 : 1395 1401.
3. Rubens FD, Mesana T : The inflammatory response to cardiopulmonary bypass: A therapeutic overview. Perfusion 2004 19 : S5 12.
4. Campbell EJ, O'Byrne V, Stratford PW, et al : Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymer. Asaio J 1994 40 : M853 857.
5. Woodman RC, Harker LA : Bleeding complications associated with cardiopulmonary bypass. Blood 1990 76 : 1680 1697.
6. Weerasinghe A, Taylor KM : The platelet in cardiopulmonary bypass. Ann Thorac Surg 1998 66 : 2145 2152. (Pubitemid 29087232)
7. Rubens FD : Cardiopulmonary bypass technology transfer: Musings of a cardiac surgeon. J Biomater Sci Polym Ed 2002 13 : 485 499.
8. Ovrum E, Holen EA, Tangen G, et al : Completely heparinized cardiopulmonary bypass and reduced systemic heparin: Clinical and hemostatic effects. Ann Thorac Surg 1995 60 : 365 371.
9. Aldea GS, Doursounian M, O'Gara P, et al : Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: A prospective, randomized study. Ann Thorac Surg 1996 62 : 410 417 discussion 417-418.
10. Mahoney CB : Heparin-bonded circuits: Clinical outcomes and costs. Perfusion 1998 13 : 192 204. (Pubitemid 28269122)
11. Ovrum E, Am Holen E, Tangen G, et al : Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance. Ann Thorac Surg 1996 62 : 1128 1133. (Pubitemid 26340335)
12. van der Kamp KW, van Oeveren W. Contact, coagulation and platelet interaction with heparin treated equipment during heart surgery. Int J Artif Organs 1993 16 : 836 842. (Pubitemid 24095448)
13. De Somer F, Francois K, van Oeveren W, et al : Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. Eur J Cardiothorac Surg 2000 18 : 602 606. (Pubitemid 30774705)
14. De Somer F, Van BY, Caes F, et al : Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass. Perfusion 2002 17 : 39 44. (Pubitemid 34071706)
15. Pappalardo F, Della Valle P, Crescenzi G, et al : Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: A randomized controlled trial. Ann Thorac Surg 2006 81 : 886 891. (Pubitemid 43247655)
16. Schulz CM, Pritisanac A, Schutz A, et al : Effects of phospholipid-coated extracorporeal circuits on clinical outcome parameters and systemic inflammatory response in coronary artery bypass graft patients. Heart Surg Forum 2002 6 : 47 52.
17. Breuer J, Leube G, Mayer P, et al : Effects of cardiopulmonary bypass and inhaled nitric oxide on platelets in children with congenital heart defects. Eur J Pediatr 1998 157 : 194 201. (Pubitemid 28113872)
18. Boning A, Scheewe J, Ivers T, et al : Phosphorylcholine or heparin coating for pediatric extracorporeal circulation causes similar biologic effects in neonates and infants. J Thorac Cardiovasc Surg 2004 127 : 1458 1465. (Pubitemid 38560613)
19. Chung A, Wildhirt SM, Wang S, et al : Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: A pilot clinical study. J Thorac Cardiovasc Surg 2005 129 : 782 790. (Pubitemid 40487878)